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Desminopathies belong to a family of muscle disor-
ders called myofibrillar myopathies that are caused
by Desmin mutations and lead to protein aggregates
in muscle fibers. To date, the initial pathological
steps of desminopathies and the impact of desmin
aggregates in the genesis of the disease are unclear.
Using live, high-resolution microscopy, we show
that Desmin loss of function and Desmin aggregates
promote skeletal muscle defects and alter heart
biomechanics. In addition, we show that the calcium
dynamics associated with heart contraction are
impaired and are associated with sarcoplasmic retic-
ulum dilatation as well as abnormal subcellular dis-
tribution of Ryanodine receptors. Our results demon-
strate that desminopathies are associated with
perturbed excitation-contraction coupling machin-
ery and that aggregates are more detrimental than
Desmin loss of function. Additionally, we show that
pharmacological inhibition of aggregate formation
and Desmin knockdown revert these phenotypes.
Our data suggest alternative therapeutic approaches
and further our understanding of themolecular deter-
minants modulating Desmin aggregate formation.INTRODUCTION
Proteinopathies form a group of diseases with well-recognized
features mainly hallmarked by protein aggregation. Desminopa-
thies belong to themyofibrillar myopathies and comprise primary
Desmin Related Myopathy and Cardiomyopathy (DRM and
DRCM). Both DRM and DRCM are characterized by intracellular
accumulation of misfolded proteins and the presence of desmin-1564 Cell Reports 11, 1564–1576, June 16, 2015 ª2015 The Authorspositive insoluble granulofilamentous aggregates. Desmin-re-
lated diseases lead to progressive skeletal muscle weakness,
cardiomyopathy, and conduction defects (van Spaendonck-
Zwarts et al., 2011). The first symptoms of desminopathies in hu-
mans generally occur in the third decade, but the disease onset
and the rate of progression of desminopathies are highly vari-
able. Interestingly, numerous muscular disorders have been
characterized as secondary DRM by the presence of desmin ag-
gregates (Griggs et al., 2007; Hnia et al., 2011). The kinetics of
aggregate formation in vivo remains unclear, and the contribu-
tion of these aggregates to developmental defects is still un-
known. Thus, developing a model organism in which aggregate
formation can be visualized in vivo will help elucidate the devel-
opmental defects underlying desminopathies and understand
the dynamics of desmin aggregation and its impact on muscle
function during embryogenesis.
Desmin is a muscle-specific type III intermediate filament pro-
tein essential for proper muscular function (Li et al., 1996; Milner
et al., 1996). Mutations affecting desmin function or promoting
desmin aggregation canpromote skeletal or cardiacmuscle phe-
notypes or both. Desmin knockout (KO) mice (Li et al., 1996; Mil-
ner et al., 1996) exhibit a loss of lateral alignment of myofibrils
from the second week after birth. This phenotype is more severe
in the heart and leads to progressive degeneration, calcification,
and necrosis of themyocardium. Desminwas proposed to act as
a scaffolding protein providing viscoelastic properties in the
vascular wall (Lacolley et al., 2001) and stiffness tomyocytes (An-
derson et al., 2001), the lung airways (Shardonofsky et al., 2006),
as well as the cardiomyocytes (Balogh et al., 2002; Costa et al.,
2004; Rezniczek et al., 2007). The embryonic heart pumping is
dependent on the biomechanical properties of cardiomyocytes
(Forouhar et al., 2006), yet the role of desmin on heart biome-
chanics in vivo remains largely unexplored. Therefore, address-
ing whether there are mechanical mechanisms associated with
desmin function that influence heart pumping and whether des-
min aggregates affect these biomechanical mechanisms would
help to solve this issue. To date, several mouse models of
desmin-related myopathy, consisting of knockin mice carrying
specific patient’s point mutations, were generated, yet most of
themdid not present clear aggregate structures, and subsequent
phenotypes were often associated to dominant-negative effects
on the desmin network rather than to aggregate formation
(Joanne et al., 2013; Kostareva et al., 2008; Raats et al., 1996).
So far, desmin aggregation was observed in mouse cardiomyo-
cytes carrying a specific desmin mutation (Wang et al., 2001a)
or CRYAB mutation (Wang et al., 2001b). Similarly, morpholino
(MO)-mediated knockdown in zebrafish leads to cardiac and
skeletal muscle phenotype (Li et al., 2013; Vogel et al., 2009).
Yet, the role of desmin in heart function is still not well known,
but it has been suggested that desmin impacts the mechanical
properties of the cardiomyocytes (Hnia et al., 2014). Neverthe-
less, the sequence of events leading to these cellular alterations
and their temporal relationship with protein aggregation have not
yet been investigated. Thus, a comparison between desmin loss
of function and pathological desmin aggregation would help to
identify the cellular defects associated with either desmin deple-
tion or aggregate formation alone.
In this study, we used genetically engineered zebrafishmodels
allowing the comparative study of the effect of desmin aggregate
formation and desmin loss of function to answer these ques-
tions. We found that desmin loss of function and the formation
of desmin aggregates participate in multiple defects affecting
skeletal and cardiac muscles, as well as vascular development
and function in the zebrafish larvae. These defects are associ-
ated with abnormal calcium flux due to the disruption of excita-
tion-contraction (EC) coupling machinery and to an abnormal
subcellular localization of Ryanodine receptor (RyR) in both
types of mutants. We further demonstrated that the majority of
pathological phenotypes could be rescued by doxycycline treat-
ment or desmin knockdown (MO), which could be of high interest
for future treatment of desminopathies. Altogether, our results
identify Desmin as an essential element in controlling embryonic
cardiovascular and skeletal muscle function, due to its role in
controlling myocardial cell contractile properties and calcium
signaling. Furthermore, despite desmin being essential for heart
function, its reduction is beneficial when aggregates are present
and represents a potential therapeutic approach for patients.
RESULTS
Generation and Characterization of the desma Citrine
(desmaCt122aGt) and desma mCherry (desmaCt122aRGt)
Zebrafish Lines
Desmin intermediate filaments polymerize to form polymers
following gradual steps of the classical assembly of intermediate
filaments (Herrmann et al., 2009). The zebrafish desmin a
(desma) gene is homologous to human desmin with 81% similar-
ity in the protein sequences. desmin b (desmb), a second homo-
log of human Desmin sharing 83% similarity, also exists in zebra-
fish (Figure S1). qPCR experiments and in situ hybridization
showed that the expression level of desmb is low at early times
of development (around 2,500-fold lower than the level of desma
in 48 hpf wild-type embryos), and no overexpression of desmb
was observed upon desma depletion (Figure S1). Accordingly,
we conclude that the uncovered desmin protein distribution isCereminiscent of Desma and that the expression of desmb can
be neglected before 96 hpf.
Several desmin mutations have been shown to interfere with
proper filament assembly when tested in vitro (Ba¨r et al.,
2005a, 2010). Suchmutations could also promote aggregate for-
mation when transfected into cultured cells (Ba¨r et al., 2005b).
However, these observations are at the steady-state level and
do not provide information on aggregate formation and dy-
namics. In order to address the role of desmin aggregates in vivo,
we used a knockin line where citrine has been inserted between
amino acids 460 and 461 in the C terminus of desmin a. This line,
named desmaCt122aGt (or ct122aGt), was obtained from a gene
trap screen. In this genetic context, the desma gene contains
an artificial exon intercalating the citrine fluorescent protein
coding sequence within the gene. This method enables in vivo
expression of labeled Desmin at endogenous levels (Trinh
et al., 2011). For the second line, we made use of the FlipTrap
capability in the desmact122aGt line to undergo Cre-lox recombi-
nation. Upon Cre-lox recombination, the desmact122aGt is con-
verted to a mCherry fusion that truncates the Desma protein,
leading to a mCherry tag followed by a stop codon in the case
of the reverted desmaCt122aRGt (or ct122aRGt) line, leading to
the deletion of 13 C-terminal amino acids in the tail domain (Fig-
ure 1A). We analyzed the global shape of the embryo and larvae
as well as the viability of the ct122aGt and found they display no
overall defects and develop normally (Figure 1B). The insertion
of the fluorescent tag leads to Desmin aggregation in both
lines in myocardial and skeletal muscles at 48 hpf (Figures 1C
and 1D). Correlative light and electron microscopy (CLEM) using
tomography showed that ct122aGt aggregates are positioned
throughout the cytoplasm and have a fibrous structure and an
average size of 9.7 ± 0.4 mm at 48 hpf (Figures 1E and 1F; Movie
S1). We segmented the aggregates in 3D, and analysis of the
reconstructions shows that the core structure of the aggregates
is a cluster of Desmin filaments packed into a disorganized
network (Movie S1).
Similar to ct122aGt, aggregates were observed both in the
heart and skeletal muscles in the ct122aRGt line. Subsequent
analysis of the Desma aggregate size and structure revealed
that ct122aRGt aggregates are positioned throughout the cyto-
plasm similarly to what is observed in ct122aGt, but they are
more electron dense and have a more granular structure than
the ct122aGt aggregates (Figure 1E). Their average size was
also smaller (1.4 ± 0.05 mm). In the myocardium, these aggre-
gates were found preferentially close to cardiomyocyte mem-
branes (Figure S1G). The differences observed between the
ct122aGt and ct122aRGt lines suggest that Desma aggregation
properties depend on its sequence integrity. This highlights
the heterogeneity of aggregate size and shape reminiscent of
desmin mutations, which is also observed in different human
mutations (Ba¨r et al., 2005b; Brodehl et al., 2012).
Desmin Loss or Aggregation Leads to Muscle
Disorganization and Altered Organelles
Desminopathies are characterized by accumulation of granulo-
filamentous material leading to progressive muscle weakness
with specific histological hallmarks, such as misshaped and
mislocalized mitochondria, z-band streaming, and myofibrillarll Reports 11, 1564–1576, June 16, 2015 ª2015 The Authors 1565
Figure 1. Desmin Flip Trap Fish Lines,
desmact122aGt and desmact122aRGt, Enable
Formation and Visualization of Desmin Ag-
gregateswhile the desmasa5/Allele Leads
to a Loss of desma Transcripts
(A) Schematic drawing of the desma gene in WT,
desmact122aGt or ct122aGt (with citrine fusion), and
desmact122aRGt or Ct122aRGt (with mCherry
fusion) fish lines. The ct122aRGt line presents a
13-amino-acid deletion at the end of the tail
domain, and the ct122aGt line presents a full
desma sequence containing the citrine fluorescent
protein.
(B) Side views of ct122aGt and ct122aRGt zebra-
fish embryos at 55 hpf. Scale bar, 500 mm.
(C and D) Desmin aggregates are observed in
skeletal muscles (scale bar, 100 mm) (C) and in the
myocardium (scale bar, 50 mm) (D) in ct122aGt and
ct122aRGt 48-hpf embryos.
(E–G) Semicorrelative light and electron micro-
scopy of skeletal muscles of ct122aGt and
ct122aRGt 48-hpf embryos. (E) Confocal micro-
graph at high magnification of ct122aGt and
ct122aRGt embryos. Nuclei are labeled with H2B-
Cerulean. Scale bar, 5 mm. (F) Electronmicrograph
analyses of the same region showed cytosolic
aggregates (the black arrows are pointing to the
aggregates circled by the dotted lines) in ct122aGt
and ct122aRGt embryos. Scale bar, 200 nm.
(G) Electron tomography at high magnification
showing filamentous aggregate structures in
ct122aGt and compact aggregates with regular
condensed structure in the ct122aRGt (the black
arrows are pointing to the aggregates circled by
the dotted lines). Scale bar, 100 nm. ct122aGt and
ct122aRGt refers to homozygous embryos.
(H) Scheme of the WT desma gene in zebrafish.
Arrow indicates the position of the mutation in the
desma gene sequence. Sequencing of genomic
DNA from desmasa5+/+ and desmasa5/ larvae
reveals a G to T mutation resulting in a stop codon
that leads to truncated Desma in desmasa5/
mutants.
(I) Reverse transcriptase qPCR on RNA extracted
from pools of WT and desmasa5/ mutants
demonstrates defective amplification of the
mutant transcripts of exons 3–4 demonstrating
that the corresponding mRNA is degraded. The
primers used for qPCR are highlighted in (A).
(J) Immunoblot of 2 dpf WT and desmasa5/
mutants demonstrating full knockdown of Desma
protein.
(K) Side views of zebrafish desmasa5+/+ and
desmasa5/ embryos at 55 hpf.
Scale bar, 500 mm. The error bars correspond to
the SEM.
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Figure 2. Aggravation of the Skeletal Mus-
cle Phenotype Is Observed in desmact122aGt
Embryos Compared to desmasa5/
(A) Optical sections of the mid trunk region using
SHG imaging show misalignment of muscle fibers
in desmasa5/ and desmact122aGt homozygous
embryos compared to WT siblings at 48, 72, and
96 hpf. In ct122aGt mutants, muscle fiber
misalignment is often accompanied by fiber
breaks and degeneration from 48 hpf. At 96 hpf,
phenotypes are separated in to three categories:
weak (W) with misalignment only; strong (S)
(see inset at 96 hpf for the desmact122aGt
and desmasa5/) with misalignment accompa-
nied with breaks, degenerations, and/or general
decrease of the SHG intensity; and extreme (E)
(see inset at 96 hpf for the desmact122aGt) where the
SHG signal is absent because of the complete
disorganization of sarcomeric structures. Scale
bar, 20 mm.
(B) Touch-evoke response assays show reduced
swimming distance and velocity in ct122aGt em-
bryos compared to controls, while the locomotion
capacity of desmasa5/ is similar to desmasa5+/+.
(C) Electron micrograph of mitochondria (M),
sarcoplasmic reticulum (R), T-Tubules (T), and
autophagy structures (A) in controls, desmasa5/,
and ct122aGt mutants. Note the sarcomeric re-
ticulum dilatation (dR) T-tubule dilation (dT) and T-
tubule bending (bT) in desmasa5/ and the dilated
mitochondria in the ct122aGt (dM), while these
structures are normal in wild-type animals. The
ratio indicates the respective frequencies (n = 6).
ct122aGt indicates desmact122aGt homozygous
embryos. Scale bar, 100 nm.
The error bars correspond to the SEM.degeneration (Schro¨der and Schoser, 2009). In mouse, desmin
knockout (KO) leads to several histological hallmarks commonly
observed in desminopathy patients despite the absence of
desmin aggregates. A desmin KO line desmasa5/was obtained
from the Sanger Institute ENU-mutagenesis screen. The
desmasa5 allele is a point mutation leading to a premature stop
codon at the beginning of the 2B alpha helix (Figure 1H). This
leads to a complete depletion of desmin expression as verified
by desma mRNA quantification (Figure 1I) and further validated
bywestern blot (Figure 1J). This suggests that themutation leads
tomRNAdecay and that desmasa5 is a null allele. When analyzing
the viability of the desmasa5/, we found that desma depletion
does not affect early embryonic overall morphology (Figure 1K);
however, we noted that a significant fraction of mutants diedCell Reports 11, 1564–157before adult stages (25%) (Figure S2A).
Similar lethality percentagewas observed
for the ct122aGt (Figure S2A).
To assess the organization of muscle
fibers in the tails of embryos from both
desmasa5/ and ct122aGt, we used sec-
ond harmonic generation (SHG) micro-
scopy. Second harmonic light can be
generated when two photons with the
same frequency interact with non-centro-symmetric structures and are effectively combined to generate a
new photon with twice the energy (Mojzisova and Vermot, 2011).
This approach allows muscle fibers imaging without any exoge-
nous labeling at high resolution (Plotnikov et al., 2006). From
48 hpf onward, desma-null embryos present perturbed organiza-
tion of myofibrils with a misalignment of fibers (Figure 2A).
Further investigation of desma loss of function was performed
using two MOs, one translation blocking and one splice block-
ing, with a mismatch MO used as a control. Our results show
that both desma morphants lead to similar skeletal muscle phe-
notypes observed for desmasa5/ (data not shown). The same
phenotype is observed in ct122aGt embryos from 48 hpf and is
accompanied by breaks in myofibril organization in 43% of em-
bryos at 96 hpf (n = 35) (Figure 2A). In some cases, characterized6, June 16, 2015 ª2015 The Authors 1567
as ‘‘extreme phenotypes,’’ the sarcomere organization was
completely lost as no SHG signal was observed (17%). The clas-
sification of our phenotype based on SHG (from weak to strong)
is also correlated with the specific labeling of actin filaments in
the skeletal muscle of the somite using phalloidin (Figure S3). A
touch evoke assay was performed to obtain functional insight
into the observed phenotypes. ct122aGt embryos showed a
decreased swimming capacity compared to their corresponding
controls with lower swimming distance and velocity, while
desmasa5/ behaved in a similar manner to desmasa5+/+
(Figure 2B). The ultrastructure obtained by transmission elec-
tron microscopy (TEM) analysis of desmasa5/ and ct122aGt
skeletal muscles at 52 hpf (Figure 2C) showed misalignment of
muscle fibers, a concomitant misalignment of T-tubules and dila-
tation/disorganization of the sarcoplasmic reticulum (SR), while
the ER seemed unaffected in both lines. Moreover, abnormal
mitochondria and mitophagy were only observed in ct122aGt
embryos at 52 hpf. Additionally, these embryos displayed
degenerating cells with loss of material and the presence of
autophagosomes. Taken together, these data validate previ-
ously reported observations made in other models of desmino-
pathies and suggest that our lines are appropriate models to
study desmin function in vivo. Furthermore, our data indicate
that Desmin aggregates lead to a more severe muscle pheno-
type than Desmin loss at the ultrastructural, cellular, and func-
tional level.
Desma Is Required for Early Heart Function
Desmin aggregates lead to a large spectrum of phenotypes in
both skeletal and cardiac muscle. The variability of phenotypes
is often observed in cardiomyopathies and includes dilated,
hypertrophic, and restrictive cardiomyopathy. Also in certain
cases additional conduction defects are observed in adult pa-
tients (Clemen et al., 2013). Nevertheless the impact of desmin
on early heart function remains unclear. Therefore, we investi-
gate heart function in the embryo by assessing cardiac contrac-
tility using high temporal imaging of the beating heart. We found
that ct122aGt, ct122aRGt, and desmasa5/ all display an
increased heart rate at 30 and 48 hpf compared to correspond-
ing controls (Figure S4A) as well as cardiac arrhythmia (2% of
the desmasa5/ and 7% of the ct122aGt) (Figure S2B). We
next addressed heart function by measuring the difference be-
tween diastolic and systolic chamber diameter over the corre-
sponding diastolic diameter (also known as atrial and ventricular
fractional shortening (FS%) in desmasa5/ embryos and noted a
significantly lower atrial but a significantly higher ventricular FS at
48 hpf compared to desmasa5+/+. Importantly, rescue of the heart
function was observed at 48 hpf in desmasa5/ by overexpress-
ing the zebrafish desma full-length mRNA, demonstrating that
the abnormal heart function is specifically due to the loss of
Desma in the desmasa5/ (Figure S4A). Furthermore, ct122aGt
and ct122aRGt embryos present higher atrial and lower ventric-
ular FS at 48 hpf than the controls and the desma mutants. As
heart dysfunction could lead to vascular defects, we measured
flow velocity in the dorsal aorta of desmasa5/, ct122aGt, and
ct122aRGt embryos and found that desmasa5/ displayed an
increased arterial blood flow in contrast to ct122aGt and
ct122aRGt embryos, which have lower blood flow velocities1568 Cell Reports 11, 1564–1576, June 16, 2015 ª2015 The Authorscompared to controls. We also found that the blood vessel diam-
eter was more variable than the controls, which might be associ-
ated with the somitic defects (Figures S4B—S4E). These data
suggest that both desmin aggregates and levels impact wall mo-
tion in the early embryonic heart and that desminopathies can
lead to early cardiac defects and abnormal vascular flow.
Heart Biomechanics Are Perturbed upon desma
Depletion or Desmin Aggregation
To further characterize the requirement of desmin on cardiomyo-
cyte function in vivo, we addressed the contribution of desmin to
the biomechanics of the heart by monitoring key parameters
defining heart-wall motion in vivo. We investigated the heart-
contraction pattern in 4D in order to precisely quantify heart-
wall motion during a typical heartbeat (Forouhar et al., 2006).
To do so, we used the myocardial-specific Tg(myl7:EGFP)
transgenic line. 4D reconstructions were obtained for 48 hpf
Tg(myl7:egfp) desmasa5+/+ (n = 5), desmasa5/ (n = 5), and
ct122aGt (n = 6) embryos (Figure 3A; Movies S2, S3, and S4).
Quantification of the heart-wall motion in both heart chambers
showed that ct122aGt, ct122aRGt, and desmasa5/ embryos
display abnormal ventricular contraction profile (Figure 3B). As
the heart pumping depends on a contraction wave going from
the atrium to the ventricle, we used the atrioventricular canal
(AVC) displacement as a readout of the global contraction
pattern. The AVC serves as a hinge, which is passively
subjected to constraint due to the contraction of the atrium
and ventricle. Thus, the AVC lateral motion is a mark of the syn-
chronization between both chamber contractions (Figure 3C). To
quantify the chamber synchronization, we specifically tracked
the motion of the AVC cells in relation to myocardial contraction
and extracted the velocity profiles of the AVC cells in the different
conditions. As expected, in control embryos, the propagation of
regular wave leads to a single velocity peakwhen the contraction
wave traverses the AVC. In the absence of functional desmin
(ct122aRGt and desmasa5/ embryos), two velocity peaks
were typically observed, demonstrating that the contraction
wave does not spread uniformly along the length of the heart
(Figure 3D). Together, these data show that desma is required
to maintain proper synchronization of heart-wall motion and
has an important role in coordinating the contraction wave of
the heart.
Desmasa5/ and Ct122aRGt Display Alterations in the
Embryonic Heart Conduction System
It was reported that some desminopathy patients have arrhyth-
mias associated with defects in the cardiac conduction system
including calcifications (Yuri et al., 2007). Given that heart
contraction waves are directly controlled by Ca2+ propagation
in the myocardium, we tested the dynamics of Ca2+ propagation
in our models. We used GCaMP3.0, a genetically encoded Ca2+
indicator (Warp et al., 2012), which reveals Ca2+ dynamics in the
heart and the activity of the conduction system in vivo (Chi et al.,
2010). We characterized the Ca2+ transient generation in the
myocardium from desmasa5/ and ct122aRGt embryos being
double transgenic for Tg(myl7:galFF) and Tg(UAS:GCaMP3.0).
This permits imaging of Ca2+ using fast confocal microscopy
and subsequent 4D reconstruction of the heartbeat and enables
Figure 3. Heart Biomechanics Are Altered
in the Absence of desma and in the Pres-
ence of Desmin Aggregates
(A) 4D reconstructions of the heart-wall dynamics
were obtained from 2D series recorded at a rate of
120 frames/s (fps) in successive planes. Periodic
contractions were reconstructed in three di-
mensions using post acquisition synchronization
of 48-hpf embryonic hearts. Scale bar, 30 mm.
(B) Comparison of myocardial wall shape in
desmasa5+/+, desmasa5/, and ct122aGt 4D re-
constructed hearts shows a squeezing of the
ventricle in both mutants (Movies S2, S3, and S4).
The lower panels show a zoom of an optical
transverse section through the middle of
the ventricle of desmasa5+/+, desmasa5/, and
ct122aGt revealing the squeezing in absence of
functional Desma (red arrows). Scale bar, 30 mm.
(C) Schematic drawing recapitulating the myo-
cardial movements associated with heart con-
traction and the subsequent movement of the
atrioventricular canal (AVC). Examples of AVC
cells tracks are shown in the lower panel. Their
velocity was used as readout of the global
contraction pattern of the heart. Scale bar, 30 mm.
(D) Graph representing the velocity of myocardial
cell motion in the AVC region following 3D
cell tracking in desmasa5+/+, desmasa5/, and
ct122aGt.
(E) Individual nuclei were tracked automatically
and their speedwas extracted. ct122aGt indicates
desmact122aGt homozygous embryos.
The error bars correspond to the SEM.the intra-cardiac calcium fluxes to be recorded concomitantly
with the native heart-wall motion (Figure 4A; Movies S5, S6,
and S7). To quantify the Ca2+ wave, the relative fluorescence in-
tensity was measured locally over time at the base of the atrium
(1), the top of the atrium (2), the tip of the ventricle (3), and the
middle of the ventricular outer curvature (4). In controls, the
peaks of calcium intensity followed the contraction wave
exactly and clear oscillations of fluorescence matching the
contraction wave were recorded in all of the analyzed regions.
By contrast, the calcium amplitude observed at the tip of the
ventricle (region 3) was lower in desmasa5/ and ct122aRGt
embryos (1.32 ± 0.082 and 1.33 ± 0.021, respectively)
compared to their corresponding controls (1.52 ± 0.082 forCell Reports 11, 1564–157desmasa5+/+ and 1.51 ± 0.091 for
ct122aRGt/). Similar observations
were made in the region corresponding
to the outer curvature of the ventricle in
the ct122aRGt embryos (1.34 ± 0.051
compared to control 1.61 ± 0.078) (Fig-
ure 4B). These data suggest that the
absence of functional desmin filaments
leads to locally decreased Ca2+ ampli-
tude. These observations provide the
physiological basis for the aberrant
contraction wave observed in the
absence of functional desmin filamentsas well as the abnormal synchronization between atrium and
ventricle during the contraction cycles.
RyR Distribution and Localization Is Altered in
Desmasa5/ and Ct122aRGt Heart
Ca2+ flux is mostly regulated by channels that allow a fine spatio-
temporal regulation of Ca2+ turnover. Ryanodine receptor (RyR)
is a master calcium channel, which modulates the spontaneous
heartbeat during development (Wu et al., 2011). Given the fact
that SR shape is altered in our models, we asked whether the
abnormal Ca2+ flux observed in our model could be linked to
RyR distribution. At 48 hpf, RyR is expressed and localized on
the SRmembranes, while the junction of SR and T-tubules called6, June 16, 2015 ª2015 The Authors 1569
Figure 4. Ca2+ Propagation in the Beating
Heart Is Deficient in the Absence of Func-
tional Desmin
(A) Snapshots from videos corresponding to the 4D
reconstructions of a single heartbeat in Tg(myl7:
GalFF; UAS:Gcamp3.0) WT, desmasa5/, and
ct122aRGt 48-hpf embryos (Movies S5, S6, and
S7) show perturbations in the Ca2+ signal at the
ventricle tip in the absence of functional Desma.
Scale bar, 30 mm.
(B) Ca2+ intensity plots and quantification of the
amplitude of the Ca2+ peak upon contraction in
four different regions of the heart: (1) inflow tract;
(2) atrium outer curvature; (3) ventricle proximal
outer curvature; and (4) ventricle distal outer cur-
vature. The amplitude is significantly reduced in
region 3 of the desmasa5/ and in regions 3 and 4
of the ct122aRGt (n = 5 embryos, nR 10 cells for
each condition). Plots correspond to a represen-
tative example of each condition. Note that the
heart-contraction sequences for each condition
are not starting at the same moment of the
contraction cycle. Gray arrows indicate the di-
rection of blood flow through the heart. ct122aRGt
indicates desmact122aRGt homozygous embryos.
The error bars correspond to the SEM.‘‘the triad’’ (RyR localization in adult muscle) is not formed yet.
However, even in the absence of mature triad compartment,
RyR is expressed and functionally regulates the entry of calcium
in the SR to coordinate myocardial contraction (Jurynec et al.,
2008). We analyzed RyR distribution in control and in the
ct122aGt embryos (Figure 5A). We found that RyR localization
in ct122aGt is aberrantly accumulating and clustering in the
myocardial cells (Figure 5A). We next assessed the composition
of the desmin aggregates by performing solubility assay. Along
with RyR, we tested for the aB-crystallin chaperone that pellets
with desmin in the X100-Triton insoluble fraction (Wang et al.,
2001b). We found that the insoluble (Pellet) fractions contained
both aB-crystallin and RyR, along with Desmin in the ct122aGt1570 Cell Reports 11, 1564–1576, June 16, 2015 ª2015 The Authorsembryos, while these proteins were
mainly present in the soluble fractions in
controls (Figure 5B). Also, we found
that RyR localization and solubility were
also altered in absence of Desmin in
desmasa5/ heart at 48 and 72 hpf, albeit
to a lesser extent than in ct122aGt em-
bryos (Figure 5C; Figures S5A and S5B).
These results suggest that RyR distribu-
tion and function is affected in absence
of functional desmin, which could inter-
fere with gradual establishment of func-
tional EC coupling machinery in muscle
cells (Figure 5D).
desma Knockdown in ct122aGt
Restores Muscle Morphology
A key step toward obtaining novel thera-
piesofproteinopathies is thedevelopmentof approachesallowing thedecreaseof thesizeand thenumberof
aggregates. Hence, targeting desmin aggregates by decreasing
desma level in the ct122aGt linewill give us clues about the contri-
bution of misfolded desmin in the muscle phenotypes. To do
so, we used a MO-based approach to knockdown desmin in
ct122aGt line. Injection of two different MO concentrations, 33
and 100 mM, lead to a drastic reduction of skeletal muscles phe-
notypes as assessed at 48, 72, and 96 hpf usingSHGandcatego-
rized into normal (N), weak (W), strong (S), and extreme (E). We
defineda scale ofSHGphenotypes inwhichweakphenotype cor-
responds to the situation where muscle fibers are misaligned or
present abnormal curvatures (Figure 6A). A strong phenotype is
attributed when muscles display degenerated and/or broken
A B
C
D
Figure 5. Desma Aggregation or Loss of
Function Impact on Ryanodine Receptor
Localization
(A) Confocal images of RyR (red) in cardiacmuscle
from 48-hpf embryos showed homogenous and
regular labeling mostly in the myocardium (myoc,
highlighted with the white dotted lines) in control
fish (ct122aRGt/), while in desma ct122aRGt+/+
mutant hearts RyR display irregular localization
and clustering (white arrowheads). Scale bar,
30 mm.
(B) In support of (A), RyR solubility was reduced
in ct122aRGt+/+ mutant fish extracts compared
to control where the majority of RyR fraction re-
mains in the Triton X-100 fractions. aB-crystallin
solubility is also affected in ct122aRGt+/+ em-
bryos. Actin is the loading control. Bars showed
quantification from two independent experiments,
and each sample contains a mixture of 50–100
fish.
(C) Similar to (A), confocal images of cardiac
muscle from 48-hpf embryos in desmasa5/ ani-
mals crossed with the myocardium-specific
Tg(myl7:egfp) (green) line compared to controls
(Tg(myl7:egfp; desmasa5+/+)) showing mis-
localization and clustering (white arrowheads) of
RyR in the myocardium (myoc, highlighted with
the white dotted lines). Scale bar, 30 mm. myoc,
myocardium
(D) Schematic drawing of how desma loss
of function (knockout or aggregation) could
impact sarcoplasmic reticulum shape and EC-
coupling machinery particularly on RyR locali-
zation.
The error bars correspond to the SEM.fibers, a global decrease in the size of themusculature or a global
decrease in the intensity of the SHG signal. A phenotype is called
extreme when the muscle disorganization is such that no SHG
signal is observedanymore (Figure 6A). Using this scale,we found
that desma knockdown (MO-33 and 100 mM) rescues ct122aGt
muscle phenotypes with a complete disappearance of the strong
phenotype (Figure 6B). Only weak phenotypes were observed in
embryos injected with the MOs, which correlates with the drastic
decrease in both the size and number of aggregates, respectively
(Figure 6C). Interestingly, the effect observed is dose- dependent
both in terms of aggregate size, number, and swimming distance
(but not the swimming speed) and in terms of total protein
decreasewhen additional MO concentrations were used (Figures
6D–6I). Finally the knockdown was sufficient to restore normal
heart function as revealed by the rescue of the ventricular and
atrial fractional shortening, whereas heart rate remained un-
changed (Figure 6I). Our data show that the presence of aggre-
gates is the main cause of pathological features in zebrafish
models of desminopathies and that decreased desmin levels
can reduce aggregate formation and, concomitantly, the pathol-
ogy affecting the skeletal and cardiac muscles.CeDoxycycline Treatment Decreases Aggregates and
Ameliorates the Skeletal Muscle Phenotype in the
ct122aGt Line
To further validate our model, we next tested compounds or
drugs with the potential to act negatively on protein aggre-
gates in the ct122aGt line. Doxycycline (Doxy) (Zheng et al.,
2010) has raised lots of interest in the last few years and is
likely the most appropriate therapeutic approach for amelio-
rating desminopathies. Doxy treatment lowers the aggregate
content in many proteinopathies (e.g., Huntington disease)
and can partially rescue the desmin-related cardiomyopathy
phenotype in the aB-crystallin mouse model (Wang et al.,
2001b; Zheng et al., 2010). We treated ct122aGt embryos
with Doxy from 12 hpf and measured aggregate size and
number using confocal microscopy after 36 hr of treatment
(Figure 7A). We performed CLEM on Doxy-treated embryos
to address the structure of the aggregates and clearance
activity. The analysis revealed a more condensed and spher-
ical structure of aggregates lacking filamentous extensions
compared to vehicle-treated embryos (Figure 7A). Moreover,
the size of the aggregates was found to be dramaticallyll Reports 11, 1564–1576, June 16, 2015 ª2015 The Authors 1571
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smaller in Doxy-treated embryos (3.2 ± 0.5 mm versus 9.7 ±
0.4 mm in untreated ct122aGt), while their number is increased
(Figure 7B). We also found that Doxy-ct122aGt embryos dis-
played a weak phenotype according to our SHG analysis
(100% versus 50% in corresponding controls at 72 hpf) (Fig-
ure 7C) suggesting that Doxy could fragment or/and inhibit
the formation of big aggregates, which impact muscle pheno-
type. Doxy could also restore normal swimming distance sug-
gesting that cellular distribution of aggregates as well as their
size may have a direct impact on the severity of the pheno-
types (Figure 7D). Furthermore, we found that Doxy restored
normal ventricular heart rate and fractional shortening by com-
parison to the untreated embryos (Figure 7E). Interestingly, the
atrial fractional shortening is higher in the mutants (treated and
non-treated) suggesting that the rescue is heart compartment
specific and that desmin affects the fractional shortening
differently in the atrium and ventricle. We further addressed
the impact of Doxy on desmin solubility in a dose-dependent
manner. By performing solubility assays, we found that Doxy
treatment dramatically increases the desmin soluble fraction
comparable to that observed for controls using increased con-
centrations (Figure 7F). However, the beneficial impact in
terms of solubility reaches a plateau when high Doxy concen-
tration was used (50 mg/ml) (Figure 7F; Figures S6A and S6B).
We also found that the effect of the Doxy could act on estab-
lished aggregates as size and numbers of aggregates could
also be reduced following Doxy treatment after aggregate for-
mation (from 24 hpf) (Figure S7A). We tested Doxy activity
once aggregates are formed by starting the treatment at
24 hpf and found that it still leads to a significant decrease
of aggregate size and increase in their number in Doxy-
ct122aGt lines (Figure S7B). The treated embryos developed
at the same pace as controls suggesting that reduction in
aggregate size is mostly due to its specific action on aggre-
gates. We conclude that Doxy could target desmin aggregates
even once they are formed and consequently could rescue
muscular defects in the ct122aGt line. Together, these data
validate the use of our line to study drugs affecting aggregate
formation in vivo. It also unambiguously confirms that desmin
aggregates are linked to several pathological hallmarks
observed in skeletal and cardiac muscle from desminopathies.Figure 6. Reduction of Desma Level Ameliorates Skeletal and CardiacM
(A) Classification of the skeletal muscle phenotypes obtained with SHG. Normal
Weak phenotype corresponds to the situation where muscle fibers are misalig
embryonic muscle display degenerated and/or broken fibers, a global decrease
signal. A phenotype is called extreme when the muscle disorganization is such t
(B) Evaluation of phenotypes in ct122aGt injected with the 33 and 100 mMMO, un
based on the scale presented in (A) after SHG imaging.
(C) Size and number of aggregates in ct122aGt injected with two different concen
reduction in aggregate numbers, while 33 mM of MO did not reduce the aggrega
(D) Images of aggregates and corresponding SHG in ct122aGt embryos treated
Scale bar, 30 mm.
(E and F) Two additional concentration of MO showed a dose-dependent reduct
(G) All the tested concentration were employed to monitor desmin solubility ind
extracts. Actin is the loading control.
(H) Decreased desma level by MO treatment improves fish mobility but does not
(I) MO-mediated desma knockdown restore normal cardiac fractional shortening
The error bars correspond to the SEM.
CeDISCUSSION
Although the zebrafish has been used extensively to identify new
regulators of cardiac and skeletal muscle function by conducting
forward genetic screens, there has been very limited success in
identifying novel mutants displaying aggregation phenotypes
and proteinopathies using endogenously tagged proteins. By
analyzing these mutant embryos, we observed the presence
of aggregates when the protein is truncated or fused with fluo-
rescent proteins. This strategy leads to aggregates that are
morphologically similar to those observed in humans, unlike
previous animal models in which there are no (or few) desmin ag-
gregates (Hnia et al., 2014). Here, we took advantage of the ze-
brafish to analyze desmin function and desmin aggregation in
the heart muscles in vivo. We found that heart defects are visible
in zebrafish at embryonic stages and as the myocardium ma-
tures. The first signs of desminopathies are most frequently
observed in adulthood in both mouse models and patients
(Goldfarb and Dalakas, 2009). We found that embryonic heart
contractility and blood flow is abnormal in the absence of desmin
and in the presence of desmin aggregates in zebrafish. Desmin-
null mice present arterial defects attributed to altered smooth
muscle cells function where desmin is well expressed (Li et al.,
1996). In the zebrafish embryo, smooth muscle cells appear
at larvae stage. Considering that desma is not detectable in
endothelial cells, our results suggest that the reported vascular
phenotypes could result from an indirect impact of blood flow
alterations. Although infrequent or poorly diagnosed in human
desminopathies, subtle vascular abnormalities should be further
investigated in relation to heart and muscle function.
The altered cardiovascular physiology observed in desmin
mutants is accompanied with conduction defects leading to
abnormal ventricular contraction. Remodeling of gap junctions
and mislocalization of Cx43 and other mechanical junction pro-
teins like desmoplakin, plakoglobin, and N-cadherin were shown
previously in a mouse model of desmin-related cardiomyopathy
(Gard et al., 2005). Mislocalization of intercellular junction com-
ponents is commonly observed in arrhythmogenic cardiomyop-
athies and triggers a loss ofmechanical and electrical coupling of
cardiomyocytes (Agullo-Pascual et al., 2014; Asimaki et al.,
2014). We found that distribution of RyR, an essential elementuscle Phenotypes Observed in desmact122aGtHomozygous Embryos
phenotype is attributed to embryos with similar muscle shape as the controls.
ned or present abnormal curvatures. A strong phenotype is attributed when
in the size of the musculature or a global decrease in the intensity of the SHG
hat no SHG signal is observed anymore. Scale bar, 30 mm.
injected, andWT embryos from 48 to 96 hpf. The assessment of a phenotype is
trations of MO (33 and 100 mM). Embryos injected with 100 mM present a high
te number.
with 10- and 66-nM concentrations of MO or the corresponding control (Ctr).
ion in size and number of aggregates.
ex = Triton X-100 soluble desmin (S)/insoluble or pellet (P) in whole zebrafish
impact speed.
in ct122aGt line. ct122aGt indicates desmact122aGt homozygous embryos.
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Figure 7. Pharmacological Targeting of Desma Aggregates Rescue ct122aGt Phenotype
(A) Confocal and electron microscopy images showing the impact of Doxycycline (Doxy) treatment on ct122aGt muscle. Doxy-treated embryos showed more
condensed and smaller aggregates compared to the controls. Scale bar, 20 mm (SHG). Scale bar, 100 nm (TEM)
(B) Quantification of aggregate size and number in Doxy-treated embryos compared to the corresponding vehicle-treated embryos.
(C) Evaluation of the phenotypes of Doxy and vehicle-treated embryos using SHG and the scale defined in (C) show that only weak and normal phenotypes were
observed after Doxy treatment, while strong phenotypes are present in the controls. Note that the vehicle contains ethanol, which is leading to a stronger
phenotype than in the non-vehicle-treated ct122aGt line.
(D) Touch-evoke response assays showing that Doxy treatment improves swimming distance but not speed in ct122aGt.
(E) Doxy-treated ct122aGt showed increased fractional shortening (FS) in the atrium but could re-establish FS in the ventricle.
(F) Doxy treatment increases desma solubility (index of solubility) in dose-dependent manner. Actin is the loading control. ct122aRGt indicates desmact122aRGt
homozygous embryos.
The error bars correspond to the SEM.
1574 Cell Reports 11, 1564–1576, June 16, 2015 ª2015 The Authors
of the excitation contraction coupling machinery, was affected in
our models. We speculate that this could explain conduction
phenotypes in our models and observed in 62% of desminop-
athy patients (van Spaendonck-Zwarts et al., 2011). As morpho-
genesis of cardiomyocytes can be influenced by endogenous
electrical currents in the embryonic heart (Chi et al., 2010), it is
possible that desmin indirectly controls the final steps of heart
development and morphogenesis through the regulation of
Ca2+ conduction in cardiomyocytes. As our data show that the
physiological mechanism of cardiac defects in desminopathies
is associated with abnormal calcium dynamics in cardiomyo-
cytes, further analysis in mouse embryos or juveniles could high-
light similar features in higher vertebrates.
Finally, we employed a strategy to decrease the amount of
endogenous desmin (MO) or to target the desmin aggregates
(doxycycline treatment) to analyze the effects of drugs as well
as to modulate the severity of the phenotype. While biochem-
ical and cellular characterization of desmin aggregates was
extremely helpful to understand properties and dynamics of
these aggregates in vitro (Herrmann et al., 2009), this work
should help to clarify the details of the cellular basis of desmi-
nopathies in vivo. Our data also validate the use of a knock-
down strategy to decrease desmin level during early embryonic
stages, which was sufficient to restore parts of the cardiac and
muscular defects. Similarly, we showed that Doxy is likely
acting as a chemical chaperone to interfere with existent des-
min aggregates and could also inhibit gradual aggregate forma-
tion and size. We propose that future use of our desmin aggre-
gation models ct122aGt and ct122aRGt might help to apply
screening strategies for the identification of chemical com-
pounds inhibiting desmin aggregation. As new and powerful
strategies are now emerging for drug screening using whole ze-
brafish embryos, this will allow the potential of chemicals that
could be applied in humans to be investigated. In conclusion,
we have identified desmin as a potential therapeutic target
for desminopathies and generated several useful zebrafish lines
for modeling desminopathies.
EXPERIMENTAL PROCEDURES
Zebrafish Husbandry and Embryo Treatments
Animal experiments were approved by the Animal Experimentation Committee
of the Institutional Review Board of the IGBMC. The following lines were used
in this study: wild-type AB, desmact122Gta and desmact122aRGt lines (Trinh et al.,
2011), desmasa5(Kettleborough et al., 2013), Tg(myl7:egfp) (Huang et al., 2003),
Tg(myl7:ras-eGFP)s883 (D’Amico et al., 2007), Tg(fli1a:neGFP)y7 (Roman et al.,
2002), Tg(fli:gal4FFubs; UAS:kaede) (Herwig et al., 2011), Tg(myl7:GalFF;
UAS:RFP)hu6228 (Strate et al., 2015), and Tg(UAS:gcamp3.0; Gal4s1020t)
(Warp et al., 2012) and were described previously. Embryos were staged ac-
cording to hours (hpf) and days postfertilization (dpf). They were incubated
at 28.5C in 0.3% Danieau medium supplemented with 0.003% (w/v) 2-phen-
ylthiourea to inhibit pigment formation.
desmasa5 fish were genotyped using the following primers: FP: ACACA
CACTCGCCAAACAAA and RP: GTCTCAGCAACTTCCGGTTC. For imaging,
embryos were anesthetized with 0.02% Tricaine (Sigma-Aldrich) and were
mounted on glass bottom Petri dishes embedded in 0.8% low melting point
agarose (Sigma-Aldrich). Before fixation for electronmicroscopy and still heart
imaging, embryos were treated for 10 min with 40 mM 2,3-butanedione mon-
oxime (BDM) as a myosin inhibitor to have their muscle in a constant relaxed
state. Doxycycline (Sigma-Aldrich) was supplemented in the fish medium
from 12 hpf at 10 mg/ml.CeMorpholino Knockdown and mRNA Rescue
One translation start site blocking and one splice site blocking MO were de-
signed to knockdown desma (Gene Tools). desma ATG MO: GGCTGAAT
ATTTCGTGCTCATGACT, desma splice MO (exon 2-intron 2): ATGACATAA
AGTACATACAGCTCTG. desma ATG mismatched MO (GGCTCAAAATT
TGGTCCTCATCACT) was used as control. 2.3 nl of MO (100 mM) was injected
into embryos at one-cell stage. For rescue experiments in desmasa5/, full-
length zebrafish desma cDNA was obtained in pME18SFL3 (Source Biosci-
ence) and amplified using TAATACGACTCACTATAGGGACCATGAGCACGA
AATATTCAGC and GGATCCAGACATGATAAGATAC primers. The resulting
fragmentswere transcribed in vitro usingmMessagemMachine T7Kit (Ambion).
0.25 ng of the mRNA was injected into embryos at the one-cell stage.
SUPPLEMENTAL INFORMATION
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